$28M Daraprim Third-Party Antitrust Class Settlement Gets Final Approval

Mealey's (July 1, 2022, 9:47 AM EDT) -- NEW YORK — A New York federal judge on June 17 entered final judgment and an order of dismissal for a $28 million antitrust settlement for third-party payers who bought overpriced Daraprim from Vyera Pharmaceuticals LLC, Phoenixus AG and company executives Martin Shkreli and Kevin Mulleady....